Search Results
Found 1 results
510(k) Data Aggregation
(87 days)
The TPSA Calibrator is an in vitro diagnostic product intended to be used to calibrate the Total Prostate Specific Antigen method for the Dimension® clinical chemistry system with the heterogeneous immunoassay module. This product was designed to meet the needs of users to assure accurate results over the assay range of this method.
The TPSA Calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens.
The Total PSA Calibrator is a five-level product. Levels 1,2,4,5, and 6 contain 0.0, 4.0, 20.0, 50.0, and 108.0 ng/mL PSA, respectively. Level 1 is a horse serum base with no detectable PSA. Levels 2,4,5 and 6 contain a human prostate specific antigen (free PSA) in a bovine serum albumin base. Bottle values are assigned according to the process outlined in Appendix B. Level 3 is reserved for use with future methods and will not be included in the packaging at this time.
The provided text describes a "Total Prostate Specific Antigen Calibrator" which is an in vitro diagnostic product intended to be used to calibrate the Total Prostate Specific Antigen method for the Dimension® clinical chemistry system. This type of device is a calibrator, not a medical imaging or AI-driven diagnostic device. Therefore, the questions regarding acceptance criteria, study details, sample sizes, expert involvement, MRMC studies, standalone performance, and ground truth types are not applicable in the context of typical AI/imaging device evaluations.
The document focuses on demonstrating substantial equivalence to a predicate device (PSA Calibrator for Dimension® clinical chemistry system) rather than proving performance against specific acceptance criteria in a clinical study. Substantial equivalence for calibrators typically involves demonstrating similar intended use, analyte, matrix, form/storage, values, and levels.
Here's an attempt to address the questions based on the available information, noting the inapplicability of many:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly state "acceptance criteria" in the traditional sense of a clinical performance study for an AI device. Instead, the "performance" is demonstrated through a comparison to a predicate device, showing substantial equivalence.
Feature | Acceptance Criteria (from predicate comparison) | Reported Device Performance (Total Prostate Specific Antigen Calibrator) |
---|---|---|
Intended Use | Calibrator | Calibrator |
Analyte | Human PSA | Human PSA |
Matrix | Level 1 Horse Serum, Levels 2-5 BSA | Level 1 Horse Serum, Levels 2,4,5,6 BSA |
Form/Storage | Frozen (-10°C to -20°C) | Liquid (2°C to 8°C) |
Values | Assigned | Assigned |
Levels | 5 levels | 5 levels |
Packaging Config. | 1.0 mL | 2.0 mL vials, 10 vials per kit, 2 vials at each level |
2. Sample sizes used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not applicable as this is a calibrator and not an AI or imaging diagnostic device evaluated with a test set of patient data. The "test set" in this context would be the calibrator materials themselves, which are described by their composition and target values.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not applicable. Ground truth for a calibrator's values is established through a different process, typically involving reference methods, traceability to international standards, and internal validation procedures, not by expert consensus on clinical cases. The document mentions "Bottle values are assigned according to the process outlined in Appendix B" (Appendix B is not provided in the extract).
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not applicable. Adjudication methods are relevant for resolving discrepancies in expert interpretations of clinical data, which is not the type of evaluation performed for a calibrator.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This information is not applicable. MRMC studies are used to evaluate diagnostic imaging devices with human readers, not calibrators.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This information is not applicable. This device is a calibrator, not an algorithm. Its performance is inherent to its physical and chemical properties and its ability to establish reference points for an assay.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The "ground truth" for calibrator values is established through assigned values based on reference methods and standardization procedures. The document states "Bottle values are assigned according to the process outlined in Appendix B." This usually means values are traceable to higher-order reference materials or internationally accepted standards for the analyte (in this case, human PSA).
8. The sample size for the training set
This information is not applicable. Calibrators do not have a "training set" in the machine learning sense.
9. How the ground truth for the training set was established
This information is not applicable.
Ask a specific question about this device
Page 1 of 1